 |
| Modena Corona 19 vaccine. © Reuters = News 1 |
US Modena has started clinical trials of its novel coronavirus infection (Corona 19) vaccine in Japan.
Modena announced on the 21st (local time) that it has started the first and second clinical trials of the Corona 19 vaccine’mRNA-1273 (or TAK-919)’ in Japan, led by Takeda Pharmaceutical, a Japanese multinational pharmaceutical company.
The clinical trial will be conducted in 200 adults over 20 years of age compared to the placebo group. Participants will receive 100 micrograms (μg, 1 millionths of a gram) or placebo of the mRNA-1273 vaccine twice each 28-day interval for safety and immunogenicity assessment.
Modena and Takeda Pharmaceuticals plan to follow up to 12 months after vaccination for participants who have completed the second dose. Takeda Pharmaceutical plans to import 50 million doses of modder or vaccine (one dose is one dose) and distribute it in the first half of the year.
According to Reuters news agency on the 21st (local time), the two companies are aiming to obtain approval from Japanese health authorities in May.
◇ Japanese government plans to secure vaccines before the Olympics
The Japanese government is planning to secure enough vaccines before the opening of the Summer Olympics scheduled for July.
Except for Modena, Pfizer, a multinational pharmaceutical company, applied for approval of BNT162b2 to Japanese health authorities in December. It is reported that Pfizer has applied for approval by synthesizing the results of clinical trials conducted on 160 adults and global clinical trials on 40,000 from October 2020.
The Pfizer vaccine is expected to be approved as early as February. On the 21st, the Japanese government ordered an additional vaccine from Pfizer’s Corona 19.
AstraZeneca has been conducting clinical trials for the Corona 19 vaccine in Japan since September 2020, but has not yet applied for approval to the Japanese authorities.
According to Kyodo News on the 22nd, the Japanese government secured 144 million doses of Pfizer vaccine and 120 million doses of AstraZeneca vaccine, a multinational pharmaceutical company. Since martial arts are inoculated twice, it is the amount that can inoculate a total of 157 million people up to 50 million doses of modal or vaccine. Currently, Japan’s population is about 126 million.
◇Domestic Corona 19 vaccination, starting as early as mid-February
It is expected that Pfizer’s COVID-19 vaccination will begin in Korea in mid-February. The vaccine is the quantity introduced by the government from the COVAX facility, a global vaccine joint purchase alliance.
According to the quarantine authorities on that day, the government received a proposal from Kovacs to supply 50,000 vaccines in early February. The amount of COVAX is selected from Pfizer, AstraZeneca, and GSK-Sanofi vaccine. Among them, it is known that the Pfizer vaccine was decided.
First of all, when 50,000 people arrive in early February, they will receive national shipment approval within 20 days from the Ministry of Food and Drug Safety. Therefore, the actual vaccination time is expected to be mid-February as early as possible. AstraZeneca vaccination is also scheduled from the end of February.
Thereafter, 20 million units of Modena vaccine will be delivered in May, and 6 million units of Janssen vaccine will be delivered in the second quarter.